Sign in
Not yet taking people in United StatesPhase 4

Intranasal LAIV Mucosal Immunity Examination

Key facts

Who runs it
University of Maryland, Baltimore
Where
Baltimore, United StatesSee the site
Trial code
Status
Not yet recruiting
Phase
Phase 4
People taking part
25 people, planned
Starts
Feb 2027
Expected to end
Jul 2029
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Live Attenuated Influenza Vaccine
Record updated
3 September 2026

Who can take part

Age
2 years to 89 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • Patient undergoing tonsillectomy and adenoidectomy as part of the standard of care for sleep apnea

Who cannot take part

  • Already received this year's flu vaccine
  • Chronic Tonsillitis
  • Immune Deficiency

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Impact of vaccination

Where in United States

  • University of Maryland Medical CenterBaltimore, United StatesContact: Adam Kaufman, MD PhDNot yet recruiting

About the trial

What the trial wants to find out

The research of the investigators is focused on the understanding how the immune system functions and responds to intranasal vaccines. Intranasal vaccines do not lead to the same changes in the blood that intramuscular vaccines do. Therefore, the investigators want to look at the function of immune (lymphoid) organs that are near the nose. The closest immune organs are the adenoids and tonsils. Mice do not have tonsils allowing for the investigators to answer these questions. Human lymphoid tissue will allow the investigators to better understand the molecular behavior of these cells in humans.

Read full original descriptionShow less

The purpose of this protocol is to administer the FDA approved live attenuated influenza vaccine or no vaccine to patients undergoing adenoidectomy and/or tonsillectomy for obstructive sleep apnea prior to surgery and then collect the tissue (adenoid and/or tonsil tissue) that would normally be discarded from surgery. This will allow for improved understanding of what happens after vaccination.

The 2 groups in the trial

  • Interventional LAIVTreatment being tested

    Intranasal Flu Vaccine

    Treatment: Live Attenuated Influenza Vaccine

  • No InterventionNo study treatment, for comparison

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Impact of Live Attenuated Intranasal Influenza Vaccine Exposure on Mucosal Immunity
Criteria questions
Built from NCT07093281, who can take part
Record updated
3 September 2026